The outcome of clinical trials can make or break biotech stocks. The following are some of the anticipated near-term clinical trial data readouts worth keeping an eye on.
Annovis Bio Inc. (ANVS), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, is awaiting topline data from a phase III study of its lead drug candidate Buntanetap in patients with early Parkinson's disease.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.